MedPath

GRAVITI PHARMACEUTICALS PRIVATE LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

29

FDA:29

Drug Approvals

BACLOFEN

Approval Date
Jan 20, 2024
FDA

Famotidine

Approval Date
Jan 5, 2024
FDA

Gabapentin

Approval Date
Aug 29, 2023
FDA

HYDROXYZINE HYDROCHLORIDE

Approval Date
Aug 24, 2023
FDA

Chlorzoxazone

Approval Date
Aug 23, 2023
FDA

esomeprazole magnesium

Approval Date
Aug 17, 2023
FDA

escitalopram

Approval Date
May 31, 2023
FDA

Amitriptyline Hydrochloride

Approval Date
May 26, 2023
FDA

Gabapentin

Approval Date
Jan 21, 2023
FDA

Atorvastatin Calcium

Approval Date
Jan 5, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.